» Articles » PMID: 39861395

Eosinophilic Esophagitis and Cow's Milk: Mechanisms, Challenges, and Treatment Perspectives

Abstract

Eosinophilic esophagitis is a chronic, antigen-driven, immune-mediated disease characterized by esophageal dysfunction and significant eosinophilic infiltration. Its rising incidence and prevalence over recent decades reflect both increased clinical awareness and the influence of environmental factors such as dietary patterns and allergen exposure. Among food allergens, cow's milk proteins are the most commonly implicated triggers, contributing to esophageal inflammation through complex immunological pathways involving both IgE-mediated and non-IgE-mediated mechanisms. Dietary elimination of cow's milk has been shown to induce histologic remission in over 60% of pediatric patients, underscoring its pivotal role in eosinophilic esophagitis management. Despite these promising results, challenges persist, including variability in individual responses, the burden of adherence to restrictive diets, and gaps in understanding the molecular mechanisms driving cow's milk-induced esophageal inflammation. This review examines the complex relationship between eosinophilic esophagitis and cow's milk, focusing on its role in disease pathogenesis and management, offering insights into its therapeutic implications. Understanding the interplay between eosinophilic esophagitis and dietary allergens, particularly cow's milk, may inform the development of targeted interventions and improve clinical outcomes for affected patients.

References
1.
Torrijos E, Gonzalez-Mendiola R, Alvarado M, Avila R, Prieto-Garcia A, Valbuena T . Eosinophilic Esophagitis: Review and Update. Front Med (Lausanne). 2018; 5:247. PMC: 6192373. DOI: 10.3389/fmed.2018.00247. View

2.
Brozek J, Firmino R, Bognanni A, Arasi S, Ansotegui I, Assaad A . World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update - XIV - Recommendations on CMA immunotherapy. World Allergy Organ J. 2022; 15(4):100646. PMC: 9061625. DOI: 10.1016/j.waojou.2022.100646. View

3.
Ridolo E, Nicoletta F, Lombardi C, Passalacqua G, Senna G, Canonica G . Eosinophilic esophagitis and inhalant antigens: Pointing out the roles of allergic rhinitis, immunotherapy and biologic treatment. World Allergy Organ J. 2024; 17(10):100968. PMC: 11462258. DOI: 10.1016/j.waojou.2024.100968. View

4.
De Bortoli N, Visaggi P, Penagini R, Annibale B, Baiano Svizzero F, Barbara G . The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis - Definition, Clinical Presentation and Diagnosis. Dig Liver Dis. 2024; 56(6):951-963. DOI: 10.1016/j.dld.2024.02.005. View

5.
Chang X, March M, Mentch F, Nguyen K, Glessner J, Qu H . A genome-wide association meta-analysis identifies new eosinophilic esophagitis loci. J Allergy Clin Immunol. 2021; 149(3):988-998. PMC: 9579995. DOI: 10.1016/j.jaci.2021.08.018. View